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Abstract: Nuclear β-dystroglycan (β-DG) is involved in the maintenance of nuclear architecture and
function. Nonetheless, its relevance in defined nuclear processes remains to be determined. In this
study we generated a C2C12 cell-based DG-null model using CRISPR-Cas9 technology to provide
insights into the role of β-DG on nuclear processes. Since DG-null cells exhibited decreased levels of
lamin B1, we aimed to elucidate the contribution of DG to senescence, owing to the central role of
lamin B1 in this pathway. Remarkably, the lack of DG enables C2C12 cells to acquire senescent features,
including cell-cycle arrest, increased senescence-associated-β-galactosidase activity, heterochromatin
loss, aberrant nuclear morphology and nucleolar disruption. We demonstrated that genomic instability
is one driving cause of the senescent phenotype in DG-null cells via the activation of a DNA-damage
response associated with mitotic failure, as shown by the presence of multipolar mitotic spindles,
which in turn induced the formation of micronuclei and γH2AX foci (DNA-damage marker), telomere
shortening and p53/p21 upregulation. Altogether, these events might ultimately lead to premature
senescence, impeding the replication of the damaged genome. In summary, we present evidence
supporting a role for DG in protecting against senescence, through the maintenance of proper lamin
B1 expression/localization and proper mitotic spindle organization.
Keywords: β-Dystroglycan; cellular senescence; lamin B1; DNA-damage response; defective mitosis
1. Introduction
Dystroglycan (DG) is an integral membrane complex that connects the extracellular matrix (ECM)
with the intracellular actin-based cytoskeleton, providing structural stability to the plasma membrane
Int. J. Mol. Sci. 2020, 21, 4961; doi:10.3390/ijms21144961 www.mdpi.com/journal/ijms
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(PM) in different tissues and cell types [1–3]. DG is synthesized as a propeptide that separates into α-
and β-DG subunits after proteolytic cleavage [2,4,5]. Both subunits remain together at the PM through
the interaction between β-DG’s extracellular domain and α-DG’s carboxy-terminal globular domain.
While α-DG is an extracellular peripheral glycoprotein that binds to various extracellular matrix
molecules, including laminin, agrin and perlecan, β-DG is a single-pass transmembrane protein that
binds through its cytoplasmic tail to dystrophin, caveolin-3 and other cytoplasmic proteins involved in
signal transduction [6–10]. Perturbation of dystroglycan processing is associated with severe congenital
disorders and cancer progression [11,12]. In addition, DG has been implicated in cellular processes such
as signal transduction and tissue morphogenesis. DG is particularly relevant in skeletal muscle tissue,
where it has been classically described to play a key role in stabilizing the sarcolemma of myofibers
during the cycles of muscle contraction and relaxation [13]. Upon injury, muscle-specific stem cells (i.e.,
satellite cells) are activated, proliferate and differentiate into myoblasts that can fuse with pre-existing
myofibers, or form new fibers, to overcome the muscle damage. Interestingly, DG is also expressed in
satellite cells, where it is essential to enable skeletal muscle regeneration [13,14]. In myoblasts, DG plays
an important role in modulating myoblast motility and migration [15]. Therefore, DG has been proven
relevant not only in myofibers, but also in myogenic precursors for proper muscle function.
Interestingly, β-DG has the ability to traffic from PM to the nucleus, using the membranous
endosome–endoplasmic reticulum network and the importin α2/β1 nuclear import pathway [16–18].
This additional cellular localization suggests potential further roles for β-DG. For instance, nuclear
β-DG has been involved in the transcriptional regulation of androgen-responsive transcription factors in
prostate cancer [19]. We previously demonstrated that β-DG assembles with the nuclear envelope (NE)
proteins emerin and lamins A/C and B1 to maintain nuclear architecture and function in myoblasts [20].
β-DG is subject to nucleocytoplasmic shuttling with an active exportin1/CRM1-mediated nuclear
export pathway [21] that together with its nuclear import serves to tightly regulate the nuclear levels
of β-DG, thereby allowing effective interactions with binding partners at the NE interface. However,
the molecular basis underlying the role of β-DG on NE-associated functions is largely unknown.
In this study, we generated DG-null mouse myoblasts (C2C12) using CRISPR-Cas9 technology to
analyze in depth the function of β-DG in the nucleus. The initial phenotype noted in DG-null cells was
the decrease in lamin B1 levels, which was accompanied by nuclear morphology defects. Therefore,
taking the evidence that lamin B1 plays a pivotal role in cellular senescence [22–25], we analyzed the
contribution of DG to this cellular process. Cellular senescence is defined as a state of permanent cell
cycle arrest that occurs in response to different damaging stimuli, including persistent DNA damage,
telomere shortening, oxidative stress and oncogenic signaling [26–28], with silencing of lamin B1
expression being an early and necessary event for senescence to be established [22–25]. We provided
evidence showing that DG plays a protective role against senescence, because the lack of DG makes
C2C12 cells to acquire senescent features. In addition, we demonstrated that senescence signaling
in DG-null cells is triggered by mitotic failure, which in turn elicits a p53-mediated DNA-damage
response to arrest the cell cycle, leading to premature senescence.
2. Results
2.1. Generation and Characterization of CRISPR/Cas9-Mediated DG-Null C2C12 Cell Clones
To analyze in depth the functional relationship of β-DG with the NE, we engineered DG knockout
cells (DG-KO) on the mouse myogenic cell line C2C12, using CRISPR/Cas9. To silence DG expression,
C2C12 cells were transfected with a vector expressing Cas9, the red fluorescence protein (RFP) and
one of two different guide RNAs (gRNA1 and gRNA2) targeting the region downstream of the
ATG translation initiation codon within the first coding exon of the mouse Dag1 gene (Figure 1A).
After positive selection for RFP and two rounds of negative selection using the IIH6 antibody, which is
specific to theαDG laminin binding domain [1,29] fluorescence-activated cell sorting (FACS) and further
clonal expansion, two different KO lines (DG-KO1 and DG-KO2) were selected (Figure 1B; see Methods
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for details). DNA sequencing of the target site was performed to directly identify editing events.
Both DG-KO clones showed indels that generate premature stop codons; thus, only polypeptides with
presumably no biological activity are synthesized from DG-KO clones (Figure 1C).
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Owing to the functional relationship of DG with dystrophin-associated proteins (DAPs), DG-
KO clones were initially characterized by analyzing the protein levels of various DAPs, namely 
Figure 1. CRISPR/Cas9-engineered dystroglycan knockout (DG-KO) C2C12 cell clones. (A) Scheme
showing the sequences of guide RNAs (gRNA1 and gRNA2), designed to target Dag1 gene.
(B) Fluorescence-activated cell sorting (FACS) analysis on C2C12 cells, gRNA2 or none gRNA
(non-transfected cells), and stained with α-DG antibody, IIH6C4. The absence of IIH6C4 reactivity
confirmed the lack of functionally glycosylated α-DG. Non-transfected cells incubated only with
secondary antibody (2◦ Ab only) were used to adjust the population negative for α-DG immunostaining
(α-DG (-)). Percentages correspond to α-DG (-) population. (C) Sequence alignment of mouse Dag1
gene (annotated) showing the introduction of indels in DG-KO1 and DG-KO2 cell lines compared
with WT cells. Amino acid sequence shows the position of the stop codons generated in DG-KO1 and
DG-KO2 cell clones.
Owing to the functional relationship of DG with dystrophin-associated proteins (DAPs), DG-KO
clones were initially characterized by analyzing the protein levels of various DAPs, namely dystrophin
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Dp71, α-dystrobrevin and β2-syntrophin. Lysates from both DG-KO1 and DG-KO2 clones showed no
β-DG protein expression (Figure 2A; 43 kDa and 26 kDa proteins), and a drastic decrease in the levels of
all DAPs analyzed was observed, compared with WT cells (Figure 2B–D). Overall, these data validate
DG-KO clones as model for studying DG, including the role of β-DG in NE-associated processes.
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Because lamin B1, a critical NE protein, is a β-DG-interacting partner [20], we were prompted to 
evaluate the impact of the lack of DG on lamin B1 distribution and protein expression. Interestingly, 
altered immunostaining for lamin B1 and evident nuclear deformities (invaginations) were found in 
DG-KO1 and DG-KO2 cells (Figure 3A). Consistently, the percentage of cells with aberrant nuclear 
morphology was clearly higher in DG-KO cell cultures than WT cell culture (right graph). 
Morphometric analysis of nuclei (nuclear area and circularly index) confirmed significant differences 
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Figure 2. Decreased protein levels of dystrophin associated proteins in DG-KO cells. Lysates from WT,
DG-KO1 and DG-KO2 cell cultures were analyzed by SDS-PAGE/WB using specific antibodies against
β-DG (A), Dp71 (B), α-dystrobrevin (α-DB) (C), β2-syntrophin (β2-Syn) (D) and GAPDH (loading
control); representative blots are shown. Bottom graphs: relative protein expression was calculated
from three independent experiments and significant differences were calculated using one-way ANOVA
and Dunnett´s post hoc test; * p < 0.05 in comparison to WT. Data indicate the mean ± SEM.
2.2. DG Deficiency Provokes Altered Localization and Decreased Protein Levels of Lamin B1
Because lamin B1, a critical NE protein, is a β-DG-interacting partner [20], we were prompted to
evaluate the impact of the lack of DG on lamin B1 distribution and protein expression. Interestingly,
altered immunostaining for lamin B1 and evident nuclear deformities (invaginations) were found in
DG-KO1 and DG-KO2 cells (Figure 3A). Consistently, the percentage of cells with aberrant nuclear
morphology was clearly higher in DG-KO cell cultures than WT cell culture (right graph). Morphometric
analysis of nuclei (nuclear area and circularly index) confirmed significant differences in nuclear shape
between WT and DG-KO1 and DG-KO2 cells (Figure 3B). In line with IF/confocal microscopy images,
a significant decrease in lamin B1 levels was observed in DG-KO1 and DG-KO2 cells (Figure 3C).
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Figure 3. DG-KO cells show altered localization and decreased protein levels of lamin B1. (A) WT,
DG-KO1 and DG-KO2 cells, seeded on glass coverslips, were fixed and immunostained for lamin B1.
Nuclei were stained with diamidino-2-phenylindole (DAPI) prior to confocal laser scanning microscopy
analysis (CLSM), and typical images are show . Bar, 10 µm. Right: th bar gr ph shows the pe centage
of nuclei with invaginations, with significant differences calculated in each cell culture from three
independent experiments using one-way ANOVA and Dunnett´s post hoc test; data indicate the mean
± SEM (n = 100 nuclei per cell culture; * p < 0.05 compared to WT). (B) Nuclear morphometric analysis
was carried out on WT, DG-KO1 and DG-KO2 cells, as described in Methods from three separate
experiments; significant differences were obtained using a non-parametric Kruskal–Wallis test and post
hoc Dunn´s method. Data correspond to the mean ± SEM (n = 100 nuclei per experimental condition;
* p < 0.05 compared to WT). (C) Lysates from WT and DG-KO1 and DG-KO2 cells were analyzed
by SDS-PAGE/WB using antibodies against lamin B1 and GAPDH (loading control). Representative
blots from three separate experiments are shown, with significant differences obtained using one-way
ANOVA and Dunnett´s post hoc test; * p < 0.05 in comparison to WT. Data indicate the mean ± SEM.
Right: densitometric analysis of immunoblot autoradiograms was performed to estimate lamin B1
protein expression.
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2.3. The Loss of DG Induces the Expression of Senescence-Associated Features
Lamin B1 downregulation occurs at the onset of cell transition to senescence [23,30]. Thus,
we tested whether the reduction in lamin B1 as a consequence of DG loss would lead to a senescent
phenotype. To approach this idea, we searched for senescence characteristics in DG-null cells. Decreased
proliferative potential and a higher percentage of cells at the G0/G1 phase of the cell cycle were found
in DG-KO1 and DG-KO2 cell cultures, compared with WT cells, as shown by MTT and flow cytometry
analyses, respectively (Figure 4A,B). G0/G1 arrest might be indicative of premature senescence; thus,
the identification of senescent cells in DG-KO cultures was carried out using senescence-associated
β-galactosidase activity [SA-β-gal]. Interestingly, increased numbers of senescent cells were found in
DG-KO1 and DG-KO2 cultures (20–25%), compared with WT cells (5%) (Figure 4C). In addition to
increased β-galactosidase activity, senescent cells display large-flat cell morphology and undergo both
nucleolar stress and the loss of perinuclear chromatin [28], among other characteristics. To corroborate
the increase in senescent cells in DG-KO cultures, we searched for the presence of these features
in DG-null cell cultures, using WT cells induced to senescence by treatment with sodium butyrate
(NaBu) for ten days as a positive control for the senescent phenotype. NaBu is a histone deacetylase
inhibitor that elicits senescence via irreversible induction of cell cycle arrest [31]. WT cells treated
with NaBu showed a flattened and expanded morphology, which markedly contrasts with the typical
polygonal morphology of untreated WT cells (Figure 5A). DG-KO2 but not DG-KO1 cells showed
a subtle but statistically significant increase in cell surface, compared with WT cells, as determined
by phalloidin staining of F-actin and estimation of cell surface area (Figure 5A and right graph).
On the other hand, a marked decrease in H3K9me3 foci immunostaining (heterochromatin marker)
was observed in DG-null cells in a similar fashion to that observed in NaBu-induced senescent cells
(Figure 5B), as determined by confocal laser scanning microscopy (CLSM) and fluorescence intensity
quantification (Figure 5B and right graph). Finally, disaggregated nucleoli with a smaller area were
found in DG-KO1 and DG-KO2 cell cultures, compared with WT cells, as revealed by immunostaining
for the nucleolar protein B23 and nucleolar area quantification (Figure 5C and right graph). However,
nucleolar disaggregation was much greater in NaBu-induced senescent cells.
Collectively, the aforementioned data imply that incipient senescence is present in DG-KO cell
cultures in the absence of any detectable senescence-inducing stimuli. Thus, we assessed whether the
lack of DG sensitizes C2C12 cells to senescence induction. In line with this, the percentage of senescent
cells was significantly higher in DG-KO1 cultures (60–70%) than that in WT cells (30%) upon five
days of NaBu treatment (Figure 6A). Long-term treatment (10 days) rendered a similar percentage of
senescent cells (~75%) between WT and DG-KO cell cultures (Figure 6A).
2.4. Aberrant Multipolar Mitoses in DG-KO Cells Resulted in Micronuclei Formation and Activation of
a P53-Mediated DNA Damage Response
A previous study from our group showed that downregulation of DG in C2C12 cells results
in an increased number of centrosomes [20]. Therefore, we next assessed whether the lack of DG
would lead to aberrant mitosis and, consequently, genomic instability, contributing to the senescent
phenotype. WT, DG-KO1 and DG-KO2 cells previously arrested in S phase by double treatment
with thymidine were released to allow their progression into mitosis. Cell were immunolabeled for
α-tubulin and γ-tubulin to decorate mitotic spindles and centrosomes, respectively, and mitotic cells
were visualized by CLSM. Remarkably, a high percentage of DG-KO1 and DG-KO2 cells (80%) showed
multipolar mitotic spindles and multidirectional alignment of chromosomes, compared to WT cells
(Figure 7A). Because thymidine treatment evokes a DNA damage response by slowing the progression
of replication forks [32], we analyzed whether DG-KO cells are more prone to response to DNA damage
than WT cells, by monitoring γ-H2AX foci, a DNA repair marker [33]. In line with our hypothesis,
a dramatic increase in fluorescence intensity of γ-H2AX foci was observed in thymidine-treated
DG-KO cells (Figure 7B) compared with thymidine-treated WT cells. Furthermore, the presence of
micronuclei, another faithful indicator of DNA damage and chromosome instability [34], was frequently
Int. J. Mol. Sci. 2020, 21, 4961 7 of 18
observed in DG-KO1 (75%) and DG- KO2 (90%) cell cultures upon thymidine treatment, compared
with WT culture (20%). To support the latter result, we searched for micronuclei in the absence of
any DNA-damage-inducing agent. A significant increase in the percentage of micronuclei-contained
cells was observed in DG-KO1 (8%) and DG-KO2 (10%) cultures, compared with WT culture (4%),
as shown by lamin B1 immunostaining (Figure S1). Errors in cell division and persistent DNA damage
in DG null cells would lead to the activation of the checkpoint proteins p53 and its target proteins p21,
which in turn elicits cell cycle arrest and/or senescence. Consistent with this notion, p53 levels were
found to be increased in thymidine-treated DG-KO1 and DG-KO2 cells, while augmented levels of p21
were observed only in DG-KO1 cells, compared with WT cells (Figure 7C). Collectively, these data
imply that the lack of DG resulted in aberrant multipolar mitosis, which in turn induces a DNA damage
response via p53 activation and ultimately cell-cycle arrest.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 7 of 19 
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Figure 4. DG-KO cell cultures exhibit decreased proliferation, G0/G1 arrest and senescence.
(A) MTT-based cell proliferation assays were performed over a 10 days period in WT, DG-KO1
and DG-KO2 cell cultures. Data correspond to the mean ± SEM from three independent experiments,
with significant differences determined by one-way ANOVA; * p < 0.05 compared to WT. (B) Cell cycle
analysis on WT, DG-KO1 and DG-KO2 asynchronous cell cultures was performed by flow cytometry.
A typical graph from three independent experiments is shown. (C) Senescent cells were identified
in WT, DG-KO1 and DG-KO2 cultures by quantifying SA β-gal activity, and representative images
were acquired by light-field microscopy. Bar = 50 µM. Right: the percentage of senescent cells was
calculated, and significant differences were obtained from three separate experiments using one-way
ANOVA, followed by Dunnett´s post hoc test. Data correspond to the mean ± SEM (n = 200 cells for
each cell culture; * p < 0.05 compared to WT).
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Figure 5. DG-null cells display senescent characteristics. WT, DG-KO1 and DG-KO2 cells were seeded
on glass coverslips and fixed prior to CLSM analysis. (A) Senescent cell morphology. Cells were
labeled with DAPI nd phalloidin to visualize nuclei and ctin-ba ed cy oskeleton, respectively,
and representative images are shown. Bar, 50 µM. Right: the cellular area was estimated using
ImageJ software, with significant differences determined by non-parametric Kruskal–Wallis tests and
post hoc Dunn´s method. Data correspond to the mean ± SEM (n = 200 cells for each cell culture
and from three independent experiments). * p < 0.05 in comparison to WT). (B) Heterochromatin
loss. Cell preparations were immunostained for H3K9me3 followed by DAPI labeling to enable
nuclei visualization. Representative confocal microscope images are shown (bar, 10 µM). Right: the
fluorescent intensity of H3K9me3 foci was measured using ImageJ software, as described in Methods.
Significant differences were determined by non-parametric Kruskal–Wallis tests, followed by post
hoc Dunn´s method. Data correspond to the the mean ± SEM (n = 200 cells for each cell culture
and from three independent experiments; * p < 0.05 in comparison to WT). (C) Nucleolar disruption.
Cell preparations were immunostained for B23 and labeled with DAPI to decorate nucleoli and nuclei,
respectively. Scale bar, 10 µM. Right: nucleolar area was assessed using ImageJ software, as described
in Methods (n = 1300 nucleoli per experimental condition). Significant differences were determined by
non-parametric Kruskal–Wallis tests and post hoc Dunn´s method; data indicate the mean ± SEM.;
* p < 0.05 compared to WT.
Int. J. Mol. Sci. 2020, 21, 4961 9 of 18
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 9 of 19 
 
fluorescent intensity of H3K9me3 foci was measured using ImageJ software, as described in Methods. 
Significant differences were determined by non-parametric Kruskal–Wallis tests, followed by post 
hoc Dunn´s method. Data correspond to the the mean ± SEM (n = 200 cells for each cell culture and 
from three independent experiments; * p < 0.05 in comparison to WT). (C) Nucleolar disruption. Cell 
preparations were immunostained for B23 and labeled with DAPI to decorate nucleoli and nuclei, 
respectively. Scale bar, 10 µM. Right: nucleolar area was assessed using ImageJ software, as described 
in Methods (n = 1300 nucleoli per experimental condition). Significant differences were determined 
by non-parametric Kruskal–Wallis tests and post hoc Dunn´s method; data indicate the mean ± SEM.; 
* p < 0.05 compared to WT. 
Collectively, the aforementioned data imply that incipient senescence is present in DG-KO cell 
cultures in the absence of any detectable senescence-inducing stimuli. Thus, we assessed whether the 
lack of DG sensitizes C2C12 cells to senescence induction. In line with this, the percentage of 
senescent cells was significantly higher in DG-KO1 cultures (60–70%) than that in WT cells (30%) 
upon five days of NaBu treatment (Figure 6A). Long-term treatment (10 days) rendered a similar 
percentage of senescent cells (~75%) between WT and DG-KO cell cultures (Figure 6A). 
 
Figure 6. The loss of DG makes C2C12 cells more responsive to senescence induction. (A)WT, DG-
KO1, and DG-KO2 cell cultures were treated with sodium butyrate (NaBu) for 5 or 10 days to induce 
senescence, and senescent cells were identified by SA β-gal activity; typical images were acquired by 
light-field microscopy. Bar = 50 µM. Right: graph shows the percentage of senescent cells obtained 
from three independent assays (n = 100 cells for each cell culture). Significant differences were 
determined by one-way ANOVA followed by Dunnett´s multiple comparison test; * p < 0.05 
compared to WT. Data correspond to the mean ± SEM. 
2.4. Aberrant Multipolar Mitoses in DG-KO Cells Resulted in Micronuclei Formation and Activation of a 
P53-Mediated DNA Damage Response 
A previous study from our group showed that downregulation of DG in C2C12 cells results in 
an increased number of centrosomes [20]. Therefore, we next assessed whether the lack of DG would 
lead to aberrant mitosis and, consequently, genomic instability, contributing to the senescent 
phenotype. WT, DG-KO1 and DG-KO2 cells previously arrested in S phase by double treatment with 
thymidine were released to allow their progression into mitosis. Cell were immunolabeled for α-
tubulin and γ-tubulin to decorate mitotic spindles and centrosomes, respectively, and mitotic cells 
were visualized by CLSM. Remarkably, a high percentage of DG-KO1 and DG-KO2 cells (80%) 
showed multipolar mitotic spindles and multidirectional alignment of chromosomes, compared to 
WT cells (Figure 7A). Because thymidine treatment evokes a DNA damage response by slowing the 
progression of replication forks [32], we analyzed whether DG-KO cells are more prone to response 
to DNA damage than WT cells, by monitoring γ-H2AX foci, a DNA repair marker [33]. In line with 
our hypothesis, a dramatic increase in fluorescence intensity of γ-H2AX foci was observed in 
Figure 6. The loss of DG makes C2C12 cells more responsive to senescence induction. ( ) T, DG-KO1,
and DG-KO2 cell cultures were treated with sodium butyrate (NaBu) 5 or 10 days to induce
senescence, and senescent cells were identified by SA β-gal activity; typical images were acquired by
light-field microscopy. Bar = 50 µM. Right: graph shows the percentage of senescent cells obtained from
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thymidine and further release into cell cycle for 4 h to progress into mitosis. Afterwards, cell preparations
were immunolabeled for α-tubulin and γ-tubulin to decorate mitotic spindles and centrosomes,
respectively, and counterstained with DAPI to visualized nuclei, prior to CLSM analysis. Right.
The percentage of multipolar mitotic spindles was determined from three separate experiments (n = 50
cells from each cell culture). Significant differences were calculated using one-way ANOVA and
Dunnett´s multiple comparison test; * p < 0.05 compared to WT. Data indicate the mean ± SEM.
(B) WT, DG-KO1 and DG-KO2 cells were cultured on coverslips and treated with thymidine as per
panel A. Cell preparations were then immunolabeled for γ2HAX and counterstained with DAPI to
decorate nuclei, prior to CLSM analysis. Right: the fluorescence intensity of γ2HAX foci was calculated,
and significant differences were determined by non-parametric Kruskal–Wallis tests followed by
Dunn´s post hoc analysis. Data correspond to the mean ± SEM from three separate experiments;
* p <0.05 compared to WT. Far right: the number of cells with micronuclei was calculated and significant
differences were obtained by one-way ANOVA and Dunnett´s post hoc analyses. Data correspond to
the mean ± SEM from three independent assays (n = 100 cells for each cell culture); * p < 0.05 compared
to WT. (C) and (D) Lysates from WT, DG-KO1 and DG-KO2 cells cultures, previously treated with
thymidine as per panel A, were analyzed by SDS-PAGE/WB, using specific antibodies against p53 (C),
p21 (D) and the loading control, and representative blots from two independent experiments are shown.
Because DNA damage response can induce telomerase shortening irrespective of telomerase
activity [35], we were prompted to estimate telomerase length in DG-deficient and WT cells of
similar culture passage (6–8 passage) by in situ hybridization (FISH), using a telomere oligonucleotide
fluorescein-labeled probe (Figure 8). It is assumed that the probe hybridizes quantitatively to telomeric
repeats, and hence the integrated telomere foci fluorescence intensity of a single nucleus is directly
related to the length of their telomeres [36,37]. We observed that the fluorescence intensity of telomere
foci was significantly less intense in DG-null cells, compared with WT cells (Figure 8A).
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Figure 8. DG-KO cells exhibit telomere shortening. (A)WT, DG-KO1 and DG-KO2 cells grown on
coverslips were processed for FISH using a specific telomere probe (see Methods), and nuclei were
decorated by staining with DAPI. Representative CLSM images are shown; bar, 10 µM. The right graph
shows the relative telomere length determined by the telomere mean intensity divided by DAPI sum
intensity. Significant differences were determined by non-parametric Kruskal–Wallis tests, followed by
post hoc Dunn´s analysis. Data indicate the mean ± SEM from three separate experiments (n = 75 cells
per cell culture); * p < 0.05 compared to WT).
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3. Discussion
In this study, we generated a C12C12 myoblasts-based model with no expression of DG (α-DG and
β-DG) using CRISPR-Cas9 technology to provide insights into the nuclear function of β-DG. In earlier
studies, we showed that β-DG is involved in maintaining the structure and function of the NE [20,21];
nevertheless, the specific mechanisms underlying its role in these nuclear processes remains to be
determined. We isolated two DG-knockout clones (DG-KO1 and DG-KO2) that were generated from
two different gRNAs. We used this strategy in order to validate that the phenotypes observed were
not due to off-target cleavage by the CRISPR-Cas9 system. DG-KO cells were intentionally sorted
from the glycosylated α-DG negative population and, accordingly, expanded DG-KO clones showed
no expression of β-DG and decreased levels of dystrophin Dp71, α-dystrobrevin and β2-syntrophin,
three well characterized partners of β-DG [38], which validated our DG-deficient cell system.
We focused our research on the previously observed interaction between β-DG and lamin
B1 [20]. Lamin B1 belongs to a group of type V intermediate filament proteins known as the
lamins. These proteins are the main component of the nuclear lamina, which provides stability to
the nuclear structure, and regulates nuclear processes such as transcription, chromatin organization,
cell cycle, among others [39]. The abnormalities in the nuclear lamina observed in DG-KO cells
confirmed previous observations suggesting a key role for β-DG in maintaining the integrity of this
compartment [21]. Moreover, the decreased levels of lamin B1 in the absence of DG is particularly
relevant as the downregulation of lamin B1 is a key event mediating premature senescence [22,40].
This has been attributed to the plethora of nuclear processes that lamin B1 regulates, such as
heterochromatin architecture, cell cycle progression, nuclear morphology, gene expression and
splicing [41,42]. Therefore, we assessed whether DG-KO cells would acquire a senescent phenotype.
Consistently, DG-KO cells exhibited several senescent marks in the absence of any senescence-inducing
stimuli, including reduced cell proliferation with arrest at G0/G1, elevated SA-β-gal activity, nucleolar
disaggregation, senescent cell morphology and loss of heterochromatin. The cellular transition
to senescence is associated with extensive chromatin reorganization and gene expression changes.
Specifically, lamin B1 downregulation occurring during senescence facilitates the spatial relocalization
of perinuclear H3K9me3-positive heterochromatin [43]. Furthermore, downregulation of SUV39H1
during the establishment of senescence may promote DNA repair, leading to genome destabilization
due to deheterochromatinization of repetitive DNA, which in turn results in cell cycle arrest [44]. Thus,
lamin B1 may contribute to senescence by the spatial reorganization of chromatin and through gene
repression [43]. In this scenery, characterization of the DG-KO cell gene expression profile, including
the genomic DNA methylation pattern, will help to determine the epigenetic regulation occurring in
response to the loss of DG. It is worth noting that treatment with the histone deacetylase inhibitor
NaBu induced senescence in proliferating myoblasts and that this effect was exacerbated in DG-KO
cells. A possible explanation is that β-DG is required to stabilize lamin B1 at the nuclear lamina so
that it can attenuate induced senescence. Indeed, perturbation of β-DG nuclear trafficking causes
both mistargeting and reduced protein levels of lamin B1, leading ultimately to aberrant nuclear
architecture [21]. Thus, tight control of nuclear β-DG content is physiologically relevant to preserve
β-DG-lamin B1 interaction, thereby allowing the cell to finely tune nuclear activity in response to
cellular stimuli. While increased susceptibility to senescence might be a consequence of lamin B1
alteration in the absence of β-DG, it remains to be explored whether additional mechanisms related to
β-DG functions (e.g., signaling) are also contributing to this process.
Cellular senescence is induced by different damaging stimuli, including extended replication,
DNA damage, oxidative stress, telomere shortening and oncogenic signaling [45,46]. In an attempt
to further understand how the lack of DG results in senescence, we invoked an earlier study that
might connect DG with DNA damage. We previously demonstrated that DG downregulation
resulted in over-duplicated centrosomes in C2C12 cells [20], an aberrant characteristic associated
with multipolar mitosis [47,48]. Supporting our assumption, multipolar mitotic spindles were
frequently found in DG-null cells, compared with WT culture. Consistent with mitotic defects
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driving chromosome instability and DNA damage response [49], DG-KO cells exhibited an increased
number of micronuclei-containing cells and apparent shortening of telomeres, compared with WT cells.
The formation of micronuclei occurred to a much greater extent when DG-null cells were subjected
to thymidine-mediated DNA damage. Thymidine treatment evokes a DNA damage response by
slowing the progression of replication forks [32]. Furthermore, numerous intensely stained foci of
phosphorylated H2AX histone (γH2AX) were found in DG-KO cells after thymidine exposure. γH2AX
orchestrates DNA repair by recruiting repair factors to the surrounding of double-strand break (DSB)
sites, including MRE11/NBS1/RAD50, MDC1, 53BP1 and BRCA1 [33,50]. Supporting the idea that DG
deficiency makes the cell more prone to DNA-damage response, upregulation of the p53 pathway
(p53 and p21 proteins) was found in DG-KO cells upon thymidine treatment. p53 plays a pivotal
role for senescence induction; the DNA damage response activates ataxia telangiectasia (ATM) and
Rad3-related (ATR) kinases, which in turn activate the p53/p21 axis by phosphorylation of both p53
and its ubiquitin ligase Mdm2, leading to the stabilization of p53 levels [51]. However, differences in
p53 pathway activation between DG-KO1 and DG-KO2 cells due to inter-clonal heterogeneity cannot
be ruled out. This issue deserves further investigation.
How DG-KO cells acquire multiple centrosomes, a hallmark of cancer cells [52], is unknown.
Centrosome amplification could result from altered centrosome replication and/or cytokinesis failure.
Numerous proteins that regulate the centrosome duplication cycle have been identified, including
Polo-like kinase-4, cyclin-dependent kinase 2, and SPD-2 [53]; however, none of them has been
linked with DG so far. It is worth noting that β-DG localized to the cleavage furrow and midbody
in cytokinesis [54]; thus, DG deficiency might lead centrosome amplification through impaired
cytokinesis. Nonetheless, the fact that no binucleated cells were observed in DG-KO cultures opposes
this hypothesis. On the other hand, considering that B-type lamins have been involved in the assembly
and maintenance of mitotic spindles in Xenopus [55], it is possible that aberrant multipolar spindles
in DG-KO cells emerge, at least in part, due to depleted lamin B1 levels exhibited by DG-null cells.
Clearly, further research is required to elucidate a role for DG, if any, on centrosome duplication/mitosis
organization. Although CRISPR-Cas9 genome editing ablates the expression of both α- and β-DG,
we believe that the senescent phenotype of DG-KO cells is mechanistically linked to the nuclear
deficiency of β-DG, because lamin B1, the central hub of cellular senescence, is a β-DG interacting
partner [20,21]. Nonetheless, the possibility that the lack of α-DG drives the cell to senescence by
perturbing the outside-in signaling pathway across the ECM-cytoskeleton-nucleus axis [56] cannot
be ruled out. Furthermore, the rescue of DG expression in DG-KO cells is required to undoubtedly
demonstrate the contribution of β-DG to cellular senescence.
In summary, overall our data are consistent with the paradigm that interfering with DG function
results somehow in aberrant multipolar mitoses, which in turn evokes a p53-dependent DNA-damage
response, arresting cell cycle progression and thereby inducing senescence, to avoid propagation of
damaged genomes.
4. Materials and Methods
4.1. Cell Culturing and Treatments
Mouse C2C12 myoblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum, 50 U/ml penicillin,
50 µg/ml streptomycin, and 1 mM sodium pyruvate at 37 ◦C, in a humidified 5% CO2 cell incubator.
For senescence induction, cells were treated for 5 or 7 days with sodium butyrate (NaBu 5 mM,
Sigma-Aldrich, St Louis) diluted in PBS 1X or vehicle alone. To analyze mitosis, cells were blocked at
the S phase using double treatment with thymidine (2 mM) and then released from arrest by washing
with PBS and plating in fresh culture medium on glass coverslips for 3–4 h (metaphase-anaphase).
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4.2. Generation of DG-KO C2C12 Cell Lines by CRISPR-Cas
Two different single guide RNAs were designed to target the first coding exon of Dag1 gene,
using the crispr.mit.edu online tool: gRNA1 (5’ CCGACAACAGCCGTACCGTC 3’) and gRNA2 (5’
CCAGACGGTACGGCTGTTGT 3’) gRNAs were cloned into pSpCas9(BB)-red fluorescent protein
(RFP) plasmid (modified from pSpCas9(BB)-2A-GFP, a gift from Feng Zhan–Addgene plasmid #
48138; http://n2t.net/addgene:48138;RRID:Addgene_48138), Addgene (Watertown, MA, USA). C2C12
cells were transfected with gRNA1- or gRNA2-Cas9-RFP plasmids using lipofectamine (LTX) with
plus reagent (Thermo Fisher Scientific, Waltham, MA, USA). Forty-eight hours post transfection,
RFP positive cells were sorted using FACSAria (BD Biosciences, Woburn, MA, USA). After expansion,
cells were collected with enzyme-free cell dissociation buffer (Gibco–Thermo Fisher Scientific, Waltham,
MA, USA) and incubated with anti-CD16/CD32 antibody (Mouse BD Fc Block, 2.4G2; BD Biosciences,
Woburn, MA, USA) on ice for 5 minutes, and subsequently with anti-α-DG antibody (IIH6C4) on ice
for 30 minutes. Following PBS washes, cells were incubated with goat anti-mouse IgG-Alexa Fluor
488 secondary antibody on ice for 20 minutes. Cells were then washed with PBS and resuspended in
FACS buffer (10% FBS in PBS). Cells negative for α-DG staining were sorted by FACS and expanded.
WT cells incubated with or without IIH6C4 were used to set the gates for positive or negative α-DG
staining, respectively. Upon expansion, sorted cells had a second round of sorting for α-DG negative
staining and single cells were collected in a 96-well plate for clonal expansion. DG-KO clones were
screened for β-DG by Western blotting using anti-β-DG antibodies (MANDAG2). Two clones, DG-KO1
and DG-KO2, were expanded and characterized by sequencing the DNA region targeted by the
gRNAs, to confirm Dag1 gene disruption. Cell cultures between passage six and twelve were used for
all analyses.
4.3. Antibodies
The following primary antibodies were used. Mouse monoclonal antibodies againstα-dystrobrevin
(α-DB; BD Transduction Laboratories, Becton Dickinson, Franklin Lakes, NJ, USA), α-DG (IIH6C4
(IIH6, 05-593; Millipore, Sigma-Aldrich, St. Louis, MO, USA), β-DG (MANDAG2 [57]), α-tubulin
(sc-32293; Santa Cruz Biotechnology, CA, USA), p53 (#2524; Cell Signaling Technology, MA, USA),
p21 (#2946; Cell Signaling Thecnology, MA, USA), and GAPDH (sc-32233; Santa Cruz Biotechnology,
CA, USA). Rabbit polyclonal antibodies against B23 (sc-6013-R; Santa Cruz Biotechnology, CA, USA),
dystrophin Dp71 (+78Dp71; Genemed Synthesis Inc., San Francisco, CA, USA), lamin B1 (Ab16048;
Abcam, Cambridge, UK), γ-tubulin (sc10732; Santa Cruz Biotechnology, CA, USA), H3K9me3 (ab8898;
Abcam, Cambridge, UK) and γ-H2AX (#07-164; Millipore, Sigma-Aldrich, St. Louis, MO, USA).
Goat polyclonal antibody against β2-syntrophin (SC-13766; Santa Cruz Biotechnology, CA, USA) was
also used.
4.4. Western Blotting
C2C12 cell culture lysates were electrophoresed on 10% SDS-polyacrylamide gels and transferred
onto nitrocellulose membranes (Bio-Rad Laboratories Inc., Berkeley, CA, USA). Membranes were
blocked in TBST (100 mM Tris-HCL pH 8.0, 150 mM NaCL, 0.5% (v/v) Tween-20) with low fat-dried milk
and then incubated overnight at 4 ◦C with the appropriate primary antibodies. The specific protein
signal was developed using the corresponding secondary antibodies and enhanced chemiluminescence
western blotting detection system (ECL TM; Amersham Pharmacia, GE Healthcare), according to
the manufacturer´s instructions. Images were acquired for densitometric analysis with a Gel Doc
EZ System (Bio-Rad Laboratories Inc., Berkeley, CA, USA), using Image Lab 6.0.1 software (Bio-Rad
Laboratories Inc., Berkeley, CA, USA). To normalize protein expression from the same sample and
on the same blot, the band intensity of the target protein was divided by the band intensity of the
loading protein.
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4.5. Immunofluorescence and Confocal Microscopy Analysis
Cells cultured on coverslips were fixed with 4% paraformaldehyde in PBS for 10 min, permeabilized
with 0.2% Triton X-100-PBS, blocked with 0.5% fetal bovine serum and 3% bovine serum albumin (BSA)
in PBS and then incubated overnight at 4 ◦C with the corresponding primary antibodies. The following
day, cells were washed with 0.05% Triton-X-100-PBS for 5 min and then with PBS alone three times,
prior to be incubated for 1 h at room temperature with the appropriate fluorochrome-conjugated
secondary antibody. For double immunolabeled samples, this was followed by overnight incubation
at 4 ◦C with corresponding primary antibodies and the next day, cells were incubated with secondary
fluorochrome-conjugated antibodies. Where indicated, F-actin was labelled using TRITC-conjugated
Phalloidin (Sigma-Aldrich St. Louis, MO, USA) diluted 1:500 in PBS for 10 min at room temperature.
Finally, coverslip preparations were incubated for 20 min at room temperature with 0.2 µg/mL
diamidino-2-phenylindole (DAPI; Sigma Aldrich) for nuclei visualization, mounted on microscope
slides with VectaShield (Vector Laboratories Inc., Burlingame, CA, USA) and further analyzed by
confocal laser scanning microscopy (CLSM; Eclipse Ti Series, Nikon Corporation Healthcare Business
Unit, Japan) using a 63× (NA = 1.2) oil-immersion objective. The analysis of digitized images
was carried out using ImageJ, 1.49 software (Wayne Rasband National Institutes of Health, USA.
http://imageJ.nih.gov.ij). For morphometric analysis of nuclei, raw images were calibrated and
converted to 8-bit gray scale, to set up a threshold for nuclei selection. Then, nuclear area and circularity
parameters were calculated, as described previously [58]. The nucleolar area (µm2) was calculated
on maxima projection images, using a 3D objects counter, as described previously [59]. To quantify
the fluorescence intensity of γ-H2AX (DNA-damage marker and H3K9me3 (heterochromatin marker)
foci, the Find Maxima function from ImageJ was used, as previously described [60]. Data were plotted
using Prism6 software.
4.6. Flow Cytometry and Cell Proliferation Assays
Cells were trypsinized and washed twice with PBS prior to being fixed with 80% ethanol for 30 min,
stained for DNA with 1 µg/mL DAPI (Sigma-Aldrich) for 20 min and transferred to flow cytometry
tubes for cell cycle analysis in a BD LSR-Fortessa flow cytometer (BD Biosciences, San Jose, CA,
USA), using the ModFit LT software (Verity Software House, Topsham, ME). For proliferation assays,
cells were harvested and plated in triplicate onto 12-well microplates at (Corning, Costar), at a density
of 1 × 103 cells/mL. Cell proliferation was assessed for 10 days using the MTT [3-(4,5-dimethylthiazole)-
2-5-diphenyl tetrazolium bromide] commercial kit (Sigma-Aldrich) and following the manufacturer’s
instructions. Absorbance was measured at 570 nm on a Molecular Devices Spectra Max Plus384
microplate reader (Molecular Devices, Sunnyvale, CA, USA).
4.7. Fluorescence in Situ Hybridization (FISH) and Relative Telomere Length Determination
Cells grown on coverslips were fixed with 4% paraformaldehyde in PBS 1× for 10 min, washed
three times in PBS 1X and permeabilized with Triton 0.2% in PBS 1X for 12 min. Cell preparations were
treated for 20 min at 37 ◦C with 100 µL of RNase (1 µg/mL), washed three times with PBS 1X and dried.
Afterwards, coverslips were incubated in hybridization buffer (20 mM Na2HPO4 [Ph 7.4], 20 mM Tris
[pH 7.4], 60% formamide, 10% BSA) with 1ng/µL Cy3-conjugated telomere probe (Cy3 conjugated
G-strand probe [5´-GGGTTAGGGTTAGGGTTA-3´]) added. Coverslips were then incubated at 80 ◦C
for 2 h in the dark for denaturation, prior to incubation at room temperature overnight for hybridization.
Next day, coverslips were washed twice with SSC 2×/1% Tween 20, for 10 min at 60 ◦C; twice with SSC
1×/0.1% Tween 20 and once with SSC 0.5×/0.1% Tween 20. Finally, cells preparations were incubated
for 10 min at room temperature with DAPI (0.2 µg/µL, Sigma-Aldrich Inc.) for nuclei visualization,
washed with PBS 1×, and mounted on microscope slides with VectaShield (Vector Laboratories, Inc.,
Burlingame, CA, USA) for confocal microscopy analysis. The analysis of the number of telomere foci
and its relative length of the Q-FISH technique was performed using the Find Maxima function of
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ImageJ software, 1.49 version image analysis (Wayne Rasband National Institutes of Health, USA.
http://imageJ.nih.gov.ij). Raw images were converted to 8-bit gray scale to set up a binary mask that
allowed the analysis of fluorescence intensity of the foci within a DAPI-positive region. The relative
telomere length was calculated as follows: the telomere mean intensity was divided by the sum
intensity of the DAPI signal, as described previously [61].
4.8. Senescence-Associated β-Galactosidase (SA-β-Gal) Assay
Cells seeded on coverslips were stained with SA-β-Gal following manufacturer’s instructions
(Senescent Cell Histochemical Staining Kit, Sigma-Aldrich, St. Louis, MO, USA). Blue stained cells
expressing β-galactosidase (senescent cells) were observed under bright-field microscopy using
differential interference contrast.
5. Conclusions
In summary, overall our data are consistent with the paradigm that interfering with DG function
results somehow in aberrant multipolar mitoses, which in turn evokes a p53-dependent DNA-damage
response, arresting the cell cycle progression and thereby inducing senescence, to avoid the propagation
of damaged genomes.
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NaBu Sodium butyrate
PM Plasma membrane
NE Nuclear envelope
DAPs Dystrophin-Associated Proteins
ECM Extracellular matrix
SA-β-gal Senescence associated β-galactosidase
FACs Fluorescence-activated cell sorting
SDS PAGE Sodium dodecyl sulfate polyacrylamide gel
CLSM Confocal laser scanning microscopy analysis
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